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The actinomycetes family of bacteria is classically considered a rich source of natural
products [1]. It is often suggested that such compounds have been selected by evolution to
have biological activity [2]. For example, given the microbial-rich soil environment of the
actinomycetes native habitat, their natural products have been suggested to serve in chemical
warfare and/or signaling, which has been further connected to their leading role in providing
pharmaceutically relevant antibiotic agents [3]. Nevertheless, surprisingly few of these
molecules have been definitively assigned specific physiological roles in the native
producing bacteria.
The vast majority of actinomycetes biosynthetic diversity is devoted to the production of
either polyketides (PKs) and/or non-ribosomal peptides (NRPs), with relatively little
production of terpenoids, which are commonly found in plants and fungi, and that form the
largest class of natural products [4]. This dichotomy can perhaps be most easily seen in their
genomes, which typically contain 25–30 gene clusters (i.e., operons) assigned to natural
products biosynthesis [2], less than 5 of which produce terpenoids, with the vast majority of
the remainder producing PKs and/or NRPs. For example, the genome of Streptomyces
avermitilis MA-4680 contains 18 operons for the production of PKs and NRPs [5], but only
four prototypical (i.e., class I) terpene synthases [6]. More generally, while there are many
thousands of operons associated with bacterial PK and NRP biosynthesis [2], a recently
reported bioinformatic search found only ~120 bacterial terpene synthases [6],
demonstrating that bacterial terpenoid biosynthesis is relatively unusual.
The labdane-related diterpenoids form a natural products super-family that is characterized
by protonation-initiated bicyclization of the general diterpenoid precursor (E,E,E)-
geranylgeranyl diphosphate (GGPP) catalyzed by class II diterpene cyclases, most often to
form a labdadienyl/copalyl diphosphate product from which the nomenclature was derived
[7]. While largely associated with plants, where the requirement for gibberellin
phytohormone production has provided a biosynthetic reservoir that has been repeatedly
tapped to spawn the vast majority of the ~7,000 known such natural products [7], there are a
few examples from actinomycetes. Those where the associated biosynthetic operon have
been identified include that for terpentecin in Streptomyces griseolosporeus [8],
phenalinolactone in Streptomyces sp. Tü6071 [9], and platensimycin/platencin in
Streptomyces platensis [10], all of which are of some interest as antibiotics, although their
native physiological function is unknown. However, the focus of this review is the labdane-
related diterpenoid isotuberculosinol produced by Mycobacterium tuberculosis, which is
unusual not only as an example of a bacterial (di)terpenoid, but even further as a bacterial
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natural product for which a physiologically relevant role can be assigned, and one with
potential medical relevance at that.
While the vast majority of the actinomycetes do not cause human disease [11], the genus
mycobacteria provides notable exceptions, containing a number of species that are
pathogenic. Of particular medical relevance are those within the Mycobacterium
tuberculosis complex, as many of these closely related species and sub-species are the
causative agents of the widespread human disease Tuberculosis [12, 13]. It has been
estimated that up to 30% of the global human population is infected with such bacteria,
leading to over 1.4 million deaths annually [14]. The vast majority of human tuberculosis
cases are thought to be due to the eponymous Mycobacterium tuberculosis (Mtb) because of
its efficient infectivity in humans [15]. Moreover, the emerging multi- and extremely drug
resistant variants of Mtb underline the continued relevance of this endemic human pathogen
[16]. How the species within the Mtb complex cause tuberculosis is still not clear, as the
pathogenic mechanism seemingly consists of an as yet not fully defined multipronged attack
on the human immune system [17]. Nevertheless, while not pertinent to tuberculosis, the
polyketide mycolactones produced by Mycobacterium ulcerans serve as important virulence
factors in the resulting human disease Buruli ulcer [18], indicating the potential for a natural
product(s) to play a role in the pathogenicity of species from the Mtb complex as well.
The ability of Mtb to infect its human host relies on circumvention of the human immune
system, within which this pernicious pathogen actually carries out its lifecycle [19]. In
particular, Mtb is thought to persist and replicate inside aveolar macrophage cells, enclosed
in membrane-bound intracellular compartments derived from the phagosome into which the
original infecting bacterium was first engulfed. This obviously requires subversion of this
phagosome from its usual bacteriocidal purpose, which would normally be accomplished by
fusion with pre-formed lysosomes in a complex process termed endocyctic/phagosomal
maturation. However, Mtb containing phagosomes are arrested at an early stage of this
process, wherein these compartments only undergo a relatively slight and transient decrease
in pH, do not fuse with the protease containing lysosomes, and remain accessible to the early
recycling endosomal system [19].
How Mtb blocks phagosomal maturation is unclear, although it has been attributed to
multiple factors [19]. Nevertheless, while mycobacterial cell-surface lipids play a role, what
the other effectors are remains less definitive, with different genetic screens indicating roles
for non-overlapping sets of genes in the infection process [20–22]. Intriguingly, the only
screen targeted at early stages of infection highlighted a role for two previously unstudied
genes, Rv3377c and Rv3378c, found in a small operon that seemed to be involved in
isoprenoid/terpenoid biosynthesis [23]. Almost immediately, Rv3377c was demonstrated to
be a class II diterpene cyclase, catalyzing bicyclization and rearrangement of GGPP (1) to
produce halimadienyl/tuberculosinyl diphosphate (HPP, 2)[24](Figure 1).
Given our long-standing interest in such labdane-related diterpenoid biosynthesis [7], we
were interested in the unique activity of this cyclase, and were further intrigued by the
similar phenotypic consequences for mutations in either Rv3377c or Rv3378c. This
immediately suggests that Rv3378c encodes an enzyme that acts on HPP (2) to produce a
bioactive natural product that contributes to the ability of Mtb to arrest phagosomal
maturation. Although Rv3378c was not homologous to any known terpene synthases, we
were able to show that it has (di)terpene synthase like activity, as well as produce small
amounts of the resulting compound, finding that when this material was delivered to
macrophages on beads the pH of the resulting phagosomes stabilized at a pH ~0.5 units
above that of phagosome containing the control beads [25]. Furthermore, while this reflects
a relatively minor portion of the overall phagosomal acidification (~25%), this seemed to be
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sufficient to block subsequent fusion with protease containing vesicles (Figure 2), while
these beads containing phagosomes further remained accessible to the early endosomal
recycling system, indicating that this compound has a role in the early stages of Mtb arrest
of phagosomal maturation [25]. Spurred by the biological activity of this derived compound,
we also investigated the HPP synthase encoded by Rv3377c (MtHPS), finding that it was
susceptible to inhibition by an analog of the carbocation initially formed by protonation, 15-
aza-14,15-dihydro-GGPP, which had previously been shown to be a sub-nanomolar
inhibitor of such plant enzymes [26, 27], as well as a potentially more stable thiolo analog,
suggesting that it may be possible to inhibit MtHPS/Rv3377c in vivo [28].
In our original report, we suggested that the Rv3378c encoded diterpene synthase (MtDTS)
reacted with HPP (2) to produce a tricyclic diterpene olefin that we termed edaxadiene [25].
However, it was almost immediately suggested to us, by both Prof. Scott Rychnovsky (Univ.
California, Irvine) and Prof. Barry Snider (Brandeis Univ.), that this compound in fact
corresponded to the allylic tertiary alcohol resulting from nucleophilic addition of water
after release of the diphosphate from HPP (2). This was quickly verified by comparison of
our enzymatic product to an authentic standard synthesized by the Snider group [29], and
also demonstrated via comparative synthesis by Prof. Eric Sorenson (Princeton Univ.) and
co-workers [30]. While this structure previously had been identified as a sponge metabolite
termed nosyberkol [31], there was a closely following Japanese language publication from
the group of Prof. Tsutomu Hoshino (Nigata Univ.) indicating that MtDTS/Rv3378c
produced an equal molar mixture of this and the corresponding primary alcohol [32], which
they termed isotuberculosinol (3) and tuberculosinol (4), respectively, based on their earlier
work with MtHPS/Rv3377c wherein its enzymatic product and the derived primary alcohol
were termed tuberculosinyl diphosphate (i.e., HPP, 2) and tuberculosinol (4), respectively
[24]. While our MtDTS/Rv3377c enzymatic preparations only produce the tertiary alcohol
3, we follow the precedent set by Prof. Hoshino, and refer to this compound here as
isotuberculosinol (Figure 3).
Later reported work by the Hoshino group further demonstrated the stereochemical
conformation of the HPP (2) produced by MtHPS/Rv3377c, which is then conserved in the
(iso)tuberculosinol (3/4) product of MtDTS/Rv3378c [33]. The Hoshino group also later
reported a more detailed analysis of their MtDTS/Rv3378c enzymatic products, observing
not only the equimolar production of tuberculosinol (4) and isotuberculosinol (3), but some
stereoselectivity of the latter, with production of a 3:1 ratio of 13S- versus 13R- hydroxyl
epimers [34]. In additionally reported work, the Hoshino group found that MtDTS/Rv3378c
will react with the three known stereoisomers of copalyl diphosphate, which is the directly
bicyclized product of class II cyclization of GGPP (1), to yield similar mixtures of derived
primary and tertiary alcohols (Figure 4). Notably, this enabled a structure-activity
relationship study of (iso)tuberculosinol (3/4) activity demonstrating the importance of the
rearranged halimadienyl backbone. Specifically, isotuberculosinol (3) and tuberculosinol (4)
individually and synergistically inhibited the phagocytosis of opsonized zymosan particles
by human macrophage-like cells, but the analogous compounds derived from copalyl, rather
than halimadienyl, diphosphate failed to do so [35].
While the biochemical work described above strongly indicates a role for (iso)tuberculosinol
in arresting phagosomal maturation, these compounds were only present at very low levels
in Mtb grown in standard media [36], suggesting that such biosynthesis would need to be
increased upon phagosomal engulfment. However, microarray analyses had not reported
changes in the transcription of MtHPS/Rv3377c or MtDTS/Rv3378c during the infection
process [37–39]. Our analysis of MtHPS/Rv3377c indicated it was susceptible to inhibition
by its co-factor divalent magnesium ion [28], the levels of which are decreased in
phagosomes [40, 41], approximately over the same range we observed affecting MtHPS/
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Rv3377c activity. We had previously observed similar enzymatic behavior in the distantly
related class II diterpene cyclases specifically involved in gibberellin plant hormone
biosynthesis [42], where it seems to be physiologically relevant [43], particularly given the
matching variation in magnesium ion levels observed in response to light in the plastids
where these enzymes are found [44]. Thus, we hypothesized that the decrease in magnesium
ion level encountered upon phagosomal engulfment might act as a physiologically relevant
biochemical trigger mechanism to induce (iso)tuberculosinol (3/4) production, and were able
to provide evidence for this by demonstrating that shifting Mtb from the standard defined
growth media, containing 0.43 mM magnesium, to media containing only 0.1 mM (but
otherwise unchanged), was sufficient to induce a greater than 20-fold increase in
(iso)tuberculosinol (3/4) levels, regardless of the promoter (native or recombinant) driving
transcription of MtHPS/Rv3377c and MtDTS/Rv3378c [45](Figure 5).
The original genetic screen only found mutants of MtHPS/Rv3377c and MtDTS/Rv3378c,
with no hits found in the rest of the associated operon, which consists of Rv3377c –
Rv3383c (although Rv3380 and Rv3381c seem to represent transposable elements)[23].
This presumably reflects functional redundancy, as suggested by the homology of these to
other genes in Mtb, and/or loss of activity, as demonstrated already for Rv3379c [46], and
highlights the requirement for Rv3377c and Rv3378c to produce (iso)tuberculosinol (3/4).
Strikingly, this biosynthetic capacity is unevenly conserved across the Mtb complex – e.g.,
we earlier found that while MtHPS/Rv3377c is conserved in in all four of the Mtb strains
whose genome sequences were available at that time, the M. bovis homolog contained an
inactivating frameshift mutation that was conserved in the two sequenced strains, as well as
another that we investigated directly [28]. Given the wider host range of M. bovis and its
reduced infectivity in humans, we speculated that (iso)tuberculosinol (3/4) might play a role
in the highly infectious nature of Mtb in humans [28]. The genomes of many more Mtb and
other mycobacteria species have since been sequenced [47]. Notably, very few mutations are
found in MtHPS/Rv3377c and MtDTS/Rv3378c in the sequenced Mtb diversity strains [48],
with none in those from the highly infectious Beijing subgroup. By contrast, inactivating
mutations in these genes were found in the sequences available for all other species within
the Mtb complex, not only M. bovis, but also Mycobacterium canetti and Mycobacterium
africanum, and these genes are completely missing in the genomes of other pathogenic
mycobacteria (i.e., M. ulcerans and Mycobacterium marinum). These results then largely
support the hypothesis that (iso)tuberculosinol (3/4) plays a role in the ability of Mtb to
efficiently infect humans, which further may explain why MtHPS/Rv3377c and MtDTS/
Rv3378c were not identified in genetic screens for pathogenesis that were carried out in
mice [20, 22].
Arguably even more speculative is the origins of (iso)tuberculosinol (3/4) biosynthesis.
While M. marinum produces tetraterpene carotenoid pigments [49], (iso)tuberculosinol (3/4)
appears to have evolved from a separate gene pool. It has been noted that MtHPS/Rv3377c
and MtDTS/Rv3378c exhibit lower guanine/cytosine (GC) content (54% and 48%,
respectively) than the surrounding chromosome (65%), indicating that these were acquired
by horizontal gene transfer [23]. Intriguingly, while MtHPS/Rv3377c shares homology with
proteins from bacterial species in the actinomycetes genus Micromonospora, MtDTS has no
homology to anything outside of Mycobacteria other than a hypothetical protein from social
amoebae in the genus Dictyostelium, suggesting that MtHPS/Rv3377c and MtDTS/Rv3378c
were originally obtained from disparate sources. The results with MtDTS/Rv3378c further
highlight the unusual nature of this enzyme, which exhibits biochemical activity resembling
that observed with certain terpene synthases, but does not seem to share homologous origins
with these. On the other hand, the results with MtHPS/Rv3377c are consistent with the
previously advanced hypothesis that class II diterpene cyclases from plants, bacteria, and
fungi share homologous origins and seem to be derived from the bacterial squalene-hopene
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cyclases [50]. Nevertheless, these results also serve to demonstrate the unusual nature of
labdane-related diterpenoid biosynthesis in bacteria, as only ~110 independent such
sequences are found in BLAST searches with the MtHPS/Rv3377c amino acid sequence,
and these include verified squalene-hopene cyclases along with the known bacterial class II
diterpene cyclases [8–10, 51, 52].
In conclusion, the production of (iso)tuberculosinol (3/4) by Mtb is unusual not only in
being a rare example of a bacterial labdane-related diterpenoid, but also as an example of a
bacterial natural product that has a plausible physiological role assigned to it. Specifically,
serving as an immunomodulatory agent that seems likely to play a role in suppressing
phagosomal maturation of the endocytic compartment into which Mtb is taken up by its
aveolar macrophage host cell (Figure 6). To the extent that this contributes to infection and/
or disease progress, such biosynthesis may serve as a potential target that seems likely to be
druggable (i.e., based on the ability to inhibit the requisite MtHPS/Rv3377c with small
molecules [28, 33]). Moreover, given the novel biological activity exhibited by
(iso)tuberculosinol (3/4), it will be of significant interest to identify the molecular target
through which the observed partial suppression of phagosomal/endocytic acidification is
mediated.
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Figure 1.
Bicyclization and rearrangement of GGPP (1) to HPP (2) catalyzed by MtHPS/Rv3377c.
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Figure 2.
Effect of isotuberculosinol on maturation of macrophage phagosomes containing control (−)
or isotuberculosinol coated (+) beads, as indicated by solid and dotted lines, respectively. (a)
Effect on pH. (b) Effect on proteolytic activity. Reprinted with permission from Ref. [25].
Copyright 2009 American Chemical Society. As indicated by the arrows, the effect on pH is
observable within ~10 min., while that on proteolysis is only observed after ~20 min. The
increase in proteolysis observed in the negative control phagosome presumably reflects its
fusion with a protease containing lysosome. We hypothesize that, rather than reflecting a
distinct effect, the latter occurring blockage of lysosomal fusion is a result of incomplete
acidification.
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Figure 3.
Hydrolysis of HPP (2) to isotuberculosinol (3) and tuberculosinol (4) catalyzed by MtDTS/
Rv3378c.
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Figure 4.
Products of MtDTS/Rv3378c from reaction with various stereoisomers of copalyl
diphosphate.
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Figure 5.
Effect of magnesium depletion on isotuberculosinol production by Mtb. Reprinted with
permission from Ref. [45].
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Figure 6.
Role of isotuberculosinol in Mtb mediated block of phagosomal maturation.
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